Back to results
US 9,284,531 B2Granted
Differentiation of human pluripotent stem cells into cells expressing mature hepatocyte markers by 2D and bioreactor culture
AssigneeTakara Bio Europe AB
InventorsHarald Stachelscheid, Katrin Zeilinger, Janne Jensen, Thomas Urbaniak
Life of this patent
Estimating the term…
Abstract
The present invention relates to the use of 3D culturing systems for the derivation of hepatocyte-like cells from human pluripotent stem cells (hPS). In particular, the invention concerns the directed differentiation and maturation of human pluripotent stem cells into hepatocyte like cells in 3D hollow fiber capillary bioreactors.
Claims15
A method for differentiation of human pluripotent stem cells into cells expressing mature hepatocyte markers comprising:
- i) culturing human pluripotent stem (hPS) cells in a 2D feeder-free culture system in a low serum culture medium comprising Activin A to produce cells differentiating towards definitive endoderm (DE);
- ii) seeding the cells of step i) in a bioreactor;
- iii) perfusing the bioreactor with one or more culture media selected from a medium comprising low serum, bFGF and Activin A;
- a medium comprising serum, bFGF and Activin A;
- or a medium comprising serum, aFGF, bFGF, BMP2 and BMP4 to induce differentiation of DE into cells expressing AFP at about day 17;
- and
- iv) perfusing the bioreactors containing the AFP expressing cells of step ii) with a culture medium comprising bFGF, HGF, Oncostatin M, and Dexamethasone or in a culture medium comprising HGF, Oncostatin M, Dexamethasone, and DMSO, wherein resulting cells express AFP, albumin and urea;
- wherein the perfused cells of step (ii) differentiate into cells that express the mature hepatic markers Albumin, CYP3A4, UGT2B7, OATP-2, ADH1A, UGTIA6, CYP2C9, CYP2C19, and CYP2D6.
5 more elements
Dependencies are inferred from the claim text.